Clinical feasibility of umbilical cord tissue-derived mesenchymal stem cells in the treatment of multiple sclerosis.
J Transl Med. 2018 Mar 9;16(1):57. doi: 10.1186/s12967-018-1433-7.
J Transl Med. 2018.
PMID: 29523171
Free PMC article.
Clinical Trial.